Authors: CRAWFORD F SOTO C SUO ZM FANG CH PARKER T SAWAR A FRANGIONE B MULLAN M

Citation: F. Crawford et al., ALZHEIMERS BETA-AMYLOID VASOACTIVITY - IDENTIFICATION OF A NOVEL BETA-AMYLOID CONFORMATIONAL INTERMEDIATE, FEBS letters, 436(3), 1998, pp. 445-448

Authors: PARIS D PARKER TA TOWN T SUO ZM FANG CH HUMPHREY J CRAWFORD F MULLAN M

Citation: D. Paris et al., ROLE OF PEROXYNITRITE IN THE VASOACTIVE AND CYTOTOXIC EFFECTS OF ALZHEIMERS BETA-AMYLOID(1-40) PEPTIDE, Experimental neurology, 152(1), 1998, pp. 116-122

Authors: CRAWFORD F SUO ZM FANG CH MULLAN M

Citation: F. Crawford et al., CHARACTERISTICS OF THE IN-VITRO VASOACTIVITY OF BETA-AMYLOID PEPTIDES, Experimental neurology, 150(1), 1998, pp. 159-168

Authors: SUO ZM TAN J PLACZEK A CRAWFORD F FANG CH MULLAN M

Citation: Zm. Suo et al., ALZHEIMERS BETA-AMYLOID PEPTIDES INDUCE INFLAMMATORY CASCADE IN HUMANVASCULAR CELLS - THE ROLES OF CYTOKINES AND CD40, Brain research, 807(1-2), 1998, pp. 110-117

Authors: SUO ZM FANG CH CRAWFORD F MULLAN M

Citation: Zm. Suo et al., SUPEROXIDE FREE-RADICAL AND INTRACELLULAR CALCIUM MEDIATE A-BETA(1-42) INDUCED ENDOTHELIAL TOXICITY, Brain research, 762(1-2), 1997, pp. 144-152

Authors: CRAWFORD F SUO ZM FANG CH FRANGIONE B MULLAN M

Citation: F. Crawford et al., VASOACTIVITY OF THE ALZHEIMER A-BETA PEPTIDES AND FIBRILLOGENIC POTENTIAL, American journal of human genetics, 61(4), 1997, pp. 1929-1929